FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Shiri Navon-Venezia

Research Profile

Chemicals & Drugs

Procedures

Geographic Areas

Israel

Living Beings

Disorders

Physiology

Activities & Behaviors

Molecular Epidemiology

Co-author Network

Publications

TOP 3
Vered Schechner; Mitchell J Schwaber; David Schwartz; M Kazma; T Kotlovsky; H Mishali; Shiri Navon-Venezia; Yehuda Carmeli
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
Efraim Bilavsky; J Abu-Hanna; G Grisaru-Soen; Shiri Navon-Venezia; I Pfeffer; Vered Schechner; David Schwartz; Jalal Tarabeia; Yehuda Carmeli
Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer.
D Karfunkel; T Kotlovsky; Yehuda Carmeli; Inna Chmelnitsky; Shiri Navon-Venezia
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Shiri Navon-Venezia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vered Schechner; Mitchell J Schwaber; David Schwartz; M Kazma; T Kotlovsky; H Mishali; Shiri Navon-Venezia; Yehuda Carmeli
Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected?
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2013;19(5):451-6.
2013: Efraim Bilavsky; J Abu-Hanna; G Grisaru-Soen; Shiri Navon-Venezia; I Pfeffer; Vered Schechner; David Schwartz; Jalal Tarabeia; Yehuda Carmeli
Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer.
The Journal of hospital infection 2013;83(4):344-6.
2013: D Karfunkel; T Kotlovsky; Yehuda Carmeli; Inna Chmelnitsky; Shiri Navon-Venezia
The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2013;32(4):513-21.
2013: Mitchell J Schwaber; Sharon Tirosh-Levy; Amos Adler; Yehuda Carmeli; Inna Chmelnitsky; Eyal Klement; Samira Masarwa; Shiri Navon-Venezia; Amir Steinman
Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital.
Veterinary microbiology 2013;162(2-4):907-11.
2013: A Lerner; Shiri Navon-Venezia; J Romano; Inna Chmelnitsky; R Edgar; Yehuda Carmeli
Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae.
Antimicrobial agents and chemotherapy 2013;57(3):1474-9.
2013: Ehud Arad; Yehuda Carmeli; Daphna Frenkiel-Krispin; Rivka Glick; Eyal Gur; Eyal Kramer; Boris Kuzmenko; Shiri Navon-Venezia; Yoav Barnea
Novel rat model of methicillin-resistant Staphylococcus aureus-infected silicone breast implants: a study of biofilm pathogenesis.
Plastic and reconstructive surgery 2013;131(2):205-14.
2013: A Lerner; I Meitus; Shiri Navon-Venezia; J Abu-Hanna; A Adler; Yehuda Carmeli
Environmental contamination by carbapenem-resistant Enterobacteriaceae.
Journal of clinical microbiology 2013;51(1):177-81.
2013: Inna Chmelnitsky; R Edgar; O Hermesh; Shiri Navon-Venezia; M Shklyar; Yehuda Carmeli
Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258.
The Journal of antimicrobial chemotherapy 2013;68(1):74-83.
2012: J Moran-Gilad; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2012;31(7):1429-33.
2012: L Naparstek; E Banin; Yehuda Carmeli; Inna Chmelnitsky; Shiri Navon-Venezia
Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae.
The Journal of hospital infection 2012;81(1):15-9.
2011: Mitchell J Schwaber; Gill Smollan; Inna Chmelnitsky; Rivka Glick; Yael Kandlik; Samira Masarwa; Shiri Navon-Venezia; Gila Neria; Yehuda Carmeli
High prevalence of methicillin-resistant Staphylococcus aureus among residents and staff of long-term care facilities, involving joint and parallel evolution.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;53(9):910-3.
2011: Debby Ben-David; Yehuda Carmeli; Ilan Fridental; Samira Masarwa; Hagit Mishali; Shiri Navon-Venezia; Bina Rubinovitch; Mitchell J Schwaber; Gill Smollan
Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2011;32(9):845-53.
2011: Jacob Moran Gilad; Yehuda Carmeli; David Schwartz; Shiri Navon-Venezia
Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae.
Diagnostic microbiology and infectious disease 2011;70(4):565-7.
2011: Yehuda Carmeli; Shiri Klarfeld Lidji; Shiri Navon-Venezia; Esther Shabtai; Mitchell J Schwaber
The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study.
Diagnostic microbiology and infectious disease 2011;70(3):367-72.
2011: Amos Adler; Shiri Navon-Venezia; Jacob Moran Gilad; Evgeniya Marcos; David Schwartz; Yehuda Carmeli
Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs.
Journal of clinical microbiology 2011;49(6):2239-42.
2011: Vered Schechner; Tali Kotlovsky; Jalal Tarabeia; Meital Kazma; David Schwartz; Shiri Navon-Venezia; Yehuda Carmeli
Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2011;32(5):497-503.
2011: Moran G Goren; Inna Chmelnitsky; Yehuda Carmeli; Shiri Navon-Venezia
Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel.
The Journal of antimicrobial chemotherapy 2011;66(3):672-3.
2011: Dror Marchaim; Teena Chopra; Jason M Pogue; Federico Perez; Andrea M Hujer; Susan Rudin; Andrea Endimiani; Shiri Navon-Venezia; Jatinder Hothi; Jessica Slim; Christopher Blunden; Maryann Shango; Paul R Lephart; Hossein Salimnia; Deborah Reid; Judy Moshos; Wasif Hafeez; Suchitha Bheemreddy; Ting-Yi Chen; Sorabh Dhar; Robert A Bonomo; Keith Steven Kaye
Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan.
Antimicrobial agents and chemotherapy 2011;55(2):593-9.
2010: Azita Leavitt; Inna Chmelnitsky; Yehuda Carmeli; Shiri Navon-Venezia
Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258.
Antimicrobial agents and chemotherapy 2010;54(10):4493-6.
2010: Azita Leavitt; Yehuda Carmeli; Inna Chmelnitsky; Moran G Goren; Itzhak Ofek; Shiri Navon-Venezia
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
Antimicrobial agents and chemotherapy 2010;54(7):3002-6.
2010: Moran G Goren; Yehuda Carmeli; Mitchell J Schwaber; Inna Chmelnitsky; Vered Schechner; Shiri Navon-Venezia
Transfer of carbapenem-resistant plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in patient.
Emerging infectious diseases 2010;16(6):1014-7.
2010: Moran G Goren; Shiri Navon-Venezia; Inna Chmelnitsky; Yehuda Carmeli
Carbapenem-resistant KPC-2-producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008.
Antimicrobial agents and chemotherapy 2010;54(6):2687-91.
2010: Tara Reddy; Teena Chopra; Dror Marchaim; Jason M Pogue; George J Alangaden; Hossein Salimnia; Dina Boikov; Shiri Navon-Venezia; Robert Akins; Philip Selman; Sorabh Dhar; Keith Steven Kaye
Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system.
Antimicrobial agents and chemotherapy 2010;54(5):2235-8.
2010: Azita Leavitt; Inna Chmelnitsky; Itzhak Ofek; Yehuda Carmeli; Shiri Navon-Venezia
Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain.
The Journal of antimicrobial chemotherapy 2010;65(2):243-8.
2009: Gili Regev-Yochay; Meir Raz; Yehuda Carmeli; Bracha Shainberg; Shiri Navon-Venezia; Erica Pinco; Azita Leavitt; Nathan Keller; Galia Rahav; Richard Malley; Ethan Rubinstein
Parental Staphylococcus aureus carriage is associated with staphylococcal carriage in young children.
The Pediatric infectious disease journal 2009;28(11):960-5.
2009: Vered Schechner; Keren Straus-Robinson; David Schwartz; Iris Pfeffer; Jalal Tarabeia; Rina Moskovich; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli; Shiri Navon-Venezia
Evaluation of PCR-based testing for surveillance of KPC-producing carbapenem-resistant members of the Enterobacteriaceae family.
Journal of clinical microbiology 2009;47(10):3261-5.
2009: Inna Chmelnitsky; Orit Hermesh; Shiri Navon-Venezia; Jacob Strahilevitz; Yehuda Carmeli
Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel.
The Journal of antimicrobial chemotherapy 2009;64(4):718-22.
2009: Shmuel Benenson; Shiri Navon-Venezia; Yehuda Carmeli; Amos Adler; Jacob Strahilevitz; Allon E Moses; Colin Block
Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2009;13(5):e295-8.
2009: Brandon Kitchel; J Kamile Rasheed; Jean B Patel; Arjun Srinivasan; Shiri Navon-Venezia; Yehuda Carmeli; Alma Brolund; Christian G Giske
Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258.
Antimicrobial agents and chemotherapy 2009;53(8):3365-70.
2009: Yoav Barnea; Yehuda Carmeli; Lewis F Neville; Hamutal Kahel-Reifer; Rachel Eren; Shlomo Dagan; Shiri Navon-Venezia
Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model.
Burns : journal of the International Society for Burn Injuries 2009;35(3):390-6.
2009: Azita Leavitt; Inna Chmelnitsky; Raul Colodner; Itzhak Ofek; Yehuda Carmeli; Shiri Navon-Venezia
Ertapenem resistance among extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae isolates.
Journal of clinical microbiology 2009;47(4):969-74.
2009: Shiri Navon-Venezia; Azita Leavitt; Mitchell J Schwaber; J Kamile Rasheed; Arjun Srinivasan; Jean B Patel; Yehuda Carmeli
First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States.
Antimicrobial agents and chemotherapy 2009;53(2):818-20.
2008: Neil Woodford; Jiancheng Zhang; Marina Warner; Mary E Kaufmann; Jorge Matos; Alan Macdonald; Daniel Brudney; David Sompolinsky; Shiri Navon-Venezia; David M Livermore
Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom.
The Journal of antimicrobial chemotherapy 2008;62(6):1261-4.
2008: Yoav Barnea; Yehuda Carmeli; Boris Kuzmenko; Shiri Navon-Venezia
Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model.
The Journal of antimicrobial chemotherapy 2008;62(6):1339-43.
2008: Inna Chmelnitsky; Shiri Navon-Venezia; Jacob Strahilevitz; Yehuda Carmeli
Plasmid-mediated qnrB2 and carbapenemase gene bla(KPC-2) carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates.
Antimicrobial agents and chemotherapy 2008;52(8):2962-5.
2008: Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Yehuda Carmeli
Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel.
The Journal of antimicrobial chemotherapy 2008;62(2):289-95.
2008: Shahar Rotem; Inna S Radzishevsky; Dmitry Bourdetsky; Shiri Navon-Venezia; Yehuda Carmeli; Amram Mor
Analogous oligo-acyl-lysines with distinct antibacterial mechanisms.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2008;22(8):2652-61.
2008: Inna Chmelnitsky; Shiri Navon-Venezia; A Leavit; E Somekh; G Regev-Yochai; M Chowers; P Shitrit; Yehuda Carmeli
SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2008;27(5):385-90.
2008: Dror Marchaim; Shiri Navon-Venezia; Mitchell J Schwaber; Yehuda Carmeli
Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes.
Antimicrobial agents and chemotherapy 2008;52(4):1413-8.
2008: Mitchell J Schwaber; Shiri Klarfeld-Lidji; Shiri Navon-Venezia; David Schwartz; Azita Leavitt; Yehuda Carmeli
Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality.
Antimicrobial agents and chemotherapy 2008;52(3):1028-33.
2007: A Abbo; Yehuda Carmeli; Shiri Navon-Venezia; Yardena Siegman-Igra; Mitchell J Schwaber
Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(11):793-800.
2007: Dror Marchaim; Shiri Navon-Venezia; Azita Leavitt; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli
Molecular and epidemiologic study of polyclonal outbreaks of multidrug-resistant Acinetobacter baumannii infection in an Israeli hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007;28(8):945-50.
2007: Azita Leavitt; Shiri Navon-Venezia; Inna Chmelnitsky; Mitchell J Schwaber; Yehuda Carmeli
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Antimicrobial agents and chemotherapy 2007;51(8):3026-9.
2007: Inna S Radzishevsky; Shahar Rotem; Dmitry Bourdetsky; Shiri Navon-Venezia; Yehuda Carmeli; Amram Mor
Improved antimicrobial peptides based on acyl-lysine oligomers.
Nature biotechnology 2007;25(6):657-9.
2007: Dror Marchaim; Shiri Navon-Venezia; David Schwartz; Jalal Tarabeia; Iris Fefer; Mitchell J Schwaber; Yehuda Carmeli
Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii.
Journal of clinical microbiology 2007;45(5):1551-5.
2007: Shiri Navon-Venezia; Azita Leavitt; Yehuda Carmeli
High tigecycline resistance in multidrug-resistant Acinetobacter baumannii.
The Journal of antimicrobial chemotherapy 2007;59(4):772-4.
2007: V Vasilev; R Japheth; Ruth Yishai; N Andorn; Lea Valinsky; Shiri Navon-Venezia; Inna Chmelnitsky; Yehuda Carmeli; Dani Cohen
Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2007;26(3):189-94.
2006: Gili Regev-Yochay; Yehuda Carmeli; Meir Raz; E Pinco; Jerome Etienne; Azita Leavitt; Ethan Rubinstein; Shiri Navon-Venezia
Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2006;25(11):719-22.
2006: Oren Zimhony; Inna Chmelnitsky; Rita Bardenstein; Sorel Goland; Orly Hammer-Muntz; Shiri Navon-Venezia; Yehuda Carmeli
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Antimicrobial agents and chemotherapy 2006;50(9):3179-82.
2006: Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Plasmid-mediated imipenem-hydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel.
Antimicrobial agents and chemotherapy 2006;50(9):3098-101.
2006: Yoav Barnea; Yehuda Carmeli; Eyal Gur; Boris Kuzmenko; Andrea Gat; Lewis F Neville; Rachel Eren; Shlomo Dagan; Shiri Navon-Venezia
Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Plastic and reconstructive surgery 2006;117(7):2284-91.
2006: Michal Stein; Shiri Navon-Venezia; Inna Chmelnitsky; David Kohelet; Orna Schwartz; Orly Agmon; Eli Somekh
An outbreak of new, nonmultidrug-resistant, methicillin-resistant Staphylococcus aureus strain (sccmec type iiia variant-1) in the neonatal intensive care unit transmitted by a staff member.
The Pediatric infectious disease journal 2006;25(6):557-9.
2006: Yoav Barnea; Yehuda Carmeli; Boris Kuzmenko; Eyal Gur; Orly Hammer-Munz; Shiri Navon-Venezia
The establishment of a Pseudomonas aeruginosa-infected burn-wound sepsis model and the effect of imipenem treatment.
Annals of plastic surgery 2006;56(6):674-9.
2006: Mitchell J Schwaber; Shiri Navon-Venezia; Keith Steven Kaye; Ronen Ben-Ami; David Schwartz; Yehuda Carmeli
Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Antimicrobial agents and chemotherapy 2006;50(4):1257-62.
2006: Ronen Ben-Ami; Mitchell J Schwaber; Shiri Navon-Venezia; David Schwartz; Michael Giladi; Inna Chmelnitsky; Azita Leavitt; Yehuda Carmeli
Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(7):925-34.
2006: Mitchell J Schwaber; Shiri Navon-Venezia; Inna Chmelnitsky; Azita Leavitt; David Schwartz; Yehuda Carmeli
Utility of the VITEK 2 Advanced Expert System for identification of extended-spectrum beta-lactamase production in Enterobacter spp.
Journal of clinical microbiology 2006;44(1):241-3.
2006: Valerie Aloush; Shiri Navon-Venezia; Yardena Seigman-Igra; Shaltiel Cabili; Yehuda Carmeli
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.
Antimicrobial agents and chemotherapy 2006;50(1):43-8.
2005: Inna Chmelnitsky; Yehuda Carmeli; Azita Leavitt; Mitchell J Schwaber; Shiri Navon-Venezia
CTX-M-2 and a new CTX-M-39 enzyme are the major extended-spectrum beta-lactamases in multiple Escherichia coli clones isolated in Tel Aviv, Israel.
Antimicrobial agents and chemotherapy 2005;49(11):4745-50.
2005: Shiri Navon-Venezia; Ronen Ben-Ami; Yehuda Carmeli
Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting.
Current opinion in infectious diseases 2005;18(4):306-13.
2005: Lewis F Neville; Yoav Barnea; Orly Hammer-Munz; Eyal Gur; Boris Kuzmenko; Hamutal Kahel-Raifer; Rachel Eren; Adi Elkeles; Kanneganti G K Murthy; Csaba Szabó; Andrew L Salzman; Shlomo Dagan; Yehuda Carmeli; Shiri Navon-Venezia
Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection.
International journal of molecular medicine 2005;16(1):165-71.
2005: Mitchell J Schwaber; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
High levels of antimicrobial coresistance among extended-spectrum-beta-lactamase-producing Enterobacteriaceae.
Antimicrobial agents and chemotherapy 2005;49(5):2137-9.
2005: Ronen Ben-Ami; Shiri Navon-Venezia; David Schwartz; Y Schlezinger; Y Mekuzas; Yehuda Carmeli
Erroneous reporting of coagulase-negative Staphylococci as Kocuria spp. by the Vitek 2 system.
Journal of clinical microbiology 2005;43(3):1448-50.
2005: Jacob Schlesinger; Shiri Navon-Venezia; Inna Chmelnitsky; Orly Hammer-Münz; Azita Leavitt; Howard S Gold; Mitchell J Schwaber; Yehuda Carmeli
Extended-spectrum beta-lactamases among Enterobacter isolates obtained in Tel Aviv, Israel.
Antimicrobial agents and chemotherapy 2005;49(3):1150-6.
2005: Aharon Abbo; Shiri Navon-Venezia; Orly Hammer-Muntz; Tami Krichali; Yardena Siegman-Igra; Yehuda Carmeli
Multidrug-resistant Acinetobacter baumannii.
Emerging infectious diseases 2005;11(1):22-9.
2005: Shiri Navon-Venezia; Azita Leavitt; Ronen Ben-Ami; Yuval Aharoni; Mitchell J Schwaber; David Schwartz; Yehuda Carmeli
Evaluation of an accelerated protocol for detection of extended-spectrum beta-lactamase-producing gram-negative bacilli from positive blood cultures.
Journal of clinical microbiology 2005;43(1):439-41.
2004: Mitchell J Schwaber; Shiri Navon-Venezia; Azita Leavitt; Y Mekuzas; O Hammer-Münz; J Schlesinger; David Schwartz; Yehuda Carmeli
Failure of broth-based tests to detect methicillin-resistant Staphylococcus aureus in a clinical specimen.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(4):348-51.
2004: Shiri Navon-Venezia; Ronen Ben-Ami; Mitchell J Schwaber; Azita Leavitt; David Schwartz; Yehuda Carmeli
Protocol for the accelerated detection of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae strains from blood cultures.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2004;23(3):200-2.
2003: Ronen Ben-Ami; Shiri Navon-Venezia; David Schwartz; Yehuda Carmeli
Infection of a ventriculoatrial shunt with phenotypically variable Staphylococcus epidermidis masquerading as polymicrobial bacteremia due to various coagulase-negative Staphylococci and Kocuria varians.
Journal of clinical microbiology 2003;41(6):2444-7.
2003: Shiri Navon-Venezia; Orly Hammer-Munz; David Schwartz; Dan Turner; Boris Kuzmenko; Yehuda Carmeli
Occurrence and phenotypic characteristics of extended-spectrum beta-lactamases among members of the family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and evaluation of diagnostic tests.
Journal of clinical microbiology 2003;41(1):155-8.
2002: Shiri Navon-Venezia; Rina Feder; Leonid Gaidukov; Yehuda Carmeli; Amram Mor
Antibacterial properties of dermaseptin S4 derivatives with in vivo activity.
Antimicrobial agents and chemotherapy 2002;46(3):689-94.
2001: Amir Toren; Shiri Navon-Venezia; Eliora Z Ron; Eugene Rosenberg
Emulsifying activities of purified Alasan proteins from Acinetobacter radioresistens KA53.
Applied and environmental microbiology 2001;67(3):1102-6.
1999: Tamar Barkay; Shiri Navon-Venezia; Eliora Z Ron; Eugene Rosenberg
Enhancement of solubilization and biodegradation of polyaromatic hydrocarbons by the bioemulsifier alasan.
Applied and environmental microbiology 1999;65(6):2697-702.